Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|March 27, 2013
[Clinical characteristics and outcomes of 31 patients with primary bone lymphoma]Yangmin Zhu, Chunyan Yue, Bin Wu, et al.Leukemia Research|June 17, 2026
Efficacy and safety of BCMA-directed bispecific antibodies in relapsed and/or refractory systemic AL amyloidosis: A systematic review and meta-analysisShuhui Huang, Jiayi Luo, Guopan Yu, et al.Annals of Hematology|March 5, 2013
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysisBaohong Ping, Yangmin Zhu, Ya Gao, et al.Leukemia Research|February 9, 2020
Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experienceYangmin Zhu, Qingyan Gao, Jing Hu, et al.BMC Immunology|March 7, 2020
Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysisYangmin Zhu, Qingyan Gao, Jing Hu, et al.Annals of Hematology|June 28, 2018
Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysisYangmin Zhu, Qingyan Gao, Jun Du, et al.Discover Oncology|October 23, 2024
Treatment-free remission after discontinuation of tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a systematic review and meta-analysisZhenxiang Zheng, Hao Tang, Xinxia Zhang, et al.Medicine|September 3, 2020
Identification of the hub genes and pathways involved in acute myeloid leukemia using bioinformatics analysisYouping Tan, Liling Zheng, Yuanyuan Du, et al.European Journal of Haematology|June 27, 2015
Anti-CD19 chimeric antigen receptor-modified T cells for B-cell malignancies: a systematic review of efficacy and safety in clinical trialsYangmin Zhu, Youping Tan, Ruiming Ou, et al.Plants (Basel, Switzerland)|May 13, 2026
SsPit2A/B Effectors from Sporisorium scitamineum Interact with the Sugarcane PLCP ScRD21A and Reduce ScRD21A-Associated Cysteine Protease Activity via a Conserved LXRR MotifYangmin Zhu, Zengrong Huang, Junyi Wen, et al.Pageof 3